Bicalutamide Completed Phase 0 Trials for Adenocarcinoma of the Prostate / Hormone-Resistant Prostate Cancer / Stage IV Prostate Cancer / Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT01050842Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer